Correlation Between Molecular Partners and Revolution Medicines
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Revolution Medicines, you can compare the effects of market volatilities on Molecular Partners and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Revolution Medicines.
Diversification Opportunities for Molecular Partners and Revolution Medicines
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Molecular and Revolution is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Molecular Partners i.e., Molecular Partners and Revolution Medicines go up and down completely randomly.
Pair Corralation between Molecular Partners and Revolution Medicines
Given the investment horizon of 90 days Molecular Partners is expected to generate 1.15 times less return on investment than Revolution Medicines. In addition to that, Molecular Partners is 2.74 times more volatile than Revolution Medicines. It trades about 0.05 of its total potential returns per unit of risk. Revolution Medicines is currently generating about 0.15 per unit of volatility. If you would invest 2,448 in Revolution Medicines on September 2, 2024 and sell it today you would earn a total of 3,337 from holding Revolution Medicines or generate 136.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Revolution Medicines
Performance |
| Timeline |
| Molecular Partners |
| Revolution Medicines |
Molecular Partners and Revolution Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Revolution Medicines
The main advantage of trading using opposite Molecular Partners and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.| Molecular Partners vs. Tff Pharmaceuticals | Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. Inhibrx | Molecular Partners vs. Enliven Therapeutics |
| Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |